Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120253) titled 'The correlation study between chemokine CCL19 and its receptor CCR7 and primary Sjogren's syndrome complicated with anxiety and depression' on March 11.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Guang'an People's Hospital

Condition: Primary Sjogren's syndrome

Intervention: Primary Sjogren's syndrome without anxiety or depression group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2025-09-29

Target Sample Size: Primary Sjogren's syndrome without anxiety or depression group:40;Primary Sjogren's syndrome with anxiety and depression group...